Related references
Note: Only part of the references are listed.Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis
Boris Shulgin et al.
ONCOIMMUNOLOGY (2020)
Alopecia areata: a long-term follow-up study of 104 patients
A. Lyakhovitsky et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Risk of dermatologic and mucosal adverse events associated with PD-1/PD-L1 inhibitors in cancer patients A meta-analysis of randomized controlled trials
Wenwei Yang et al.
MEDICINE (2019)
Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?
Narjust Duma et al.
ONCOLOGIST (2019)
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer
Giulia Galli et al.
TUMORI JOURNAL (2019)
Treatment of alopecia areata: An Australian expert consensus statement
William C. Cranwel et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2019)
Immune checkpoint inhibitor-related alopecia: Insight into the pathophysiology utilizing non-invasive diagnostic techniques
Misaki Kinoshita-Ise et al.
JOURNAL OF DERMATOLOGY (2019)
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management
Emily Coleman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials
Antonino Grassadonia et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
A. Zarbo et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
Lars Hofmann et al.
EUROPEAN JOURNAL OF CANCER (2016)
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
Camille Hua et al.
JAMA DERMATOLOGY (2016)
Hair Follicle Mesenchyme-Associated PD-L1 Regulates T-Cell Activation Induced Apoptosis: A Potential Mechanism of Immune Privilege
Xiaojie Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Lifetime Incidence Risk of Alopecia Areata Estimated at 2.1% by Rochester Epidemiology Project, 1990-2009
Sultan A. Mirzoyev et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
Taisuke Ito et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2014)
Cytotoxic T-lymphocyte antigen 4 (CTLA4)+49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population
Francesca Megiorni et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)
Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum
Bin Zhang et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2013)
Hepatitis C Treatment and Alopecia Totalis
Carolyn Goh
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2013)
Genetic Variants in CTLA4 Are Strongly Associated with Alopecia Areata
Karsten K. -G. John et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Alopecia areata update Part II. Treatment
Abdullah Alkhalifah et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
Lynn Petukhova et al.
NATURE (2010)
Management of alopecia areata
M. J. Harries et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Alopecia areata: A long term follow-up study of 191 patients
Antonella Tosti et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent
SH Jaber et al.
ARCHIVES OF DERMATOLOGY (2006)
Share Paper
